RFHP 2019 Final Presentation Topics
Question #1: Gun Violence
Baltimore has historically been one of the most dangerous cities in the country for gun violence. Homicide, the leading cause of death for African-American males aged 15-24, has become a prominent public health concern for the city and the state of Maryland. The National Network of Hospital Based Violence Intervention Programs has succeeded in bringing forth a bill to the Maryland General Assembly which provides 10 million dollars in grant funding for its programs.
You direct the Baltimore City Health Department. You anticipate receiving state funds to target gun violence in your jurisdiction. In considering the bill, your state legislature seeks your stakeholder input and asks, “is funding hospital based violence intervention programs the most effective way to mitigate gun violence in Baltimore?” In your response, consider the state’s limited financial resources, potential programmatic tradeoffs, and propose at least two viable state policy alternatives to address your local gun violence crisis.
Baltimore has historically been one of the most dangerous cities in the country for gun violence. Homicide, the leading cause of death for African-American males aged 15-24, has become a prominent public health concern for the city and the state of Maryland. The National Network of Hospital Based Violence Intervention Programs has succeeded in bringing forth a bill to the Maryland General Assembly which provides 10 million dollars in grant funding for its programs.
You direct the Baltimore City Health Department. You anticipate receiving state funds to target gun violence in your jurisdiction. In considering the bill, your state legislature seeks your stakeholder input and asks, “is funding hospital based violence intervention programs the most effective way to mitigate gun violence in Baltimore?” In your response, consider the state’s limited financial resources, potential programmatic tradeoffs, and propose at least two viable state policy alternatives to address your local gun violence crisis.
Question #2: Immigration
House Democrats have become increasingly critical of The Trump Administration’s homeland security policies, including indefinite detention of children and family separation. The US House of Representatives Committee on Homeland Security is convening health professionals to discuss how such policies might contribute to adverse childhood experiences (ACEs) in a hearing entitled, “Adverse Impacts of Department of Department of Homeland Security Policies on Children.”
You are a pediatrician at Children’s National Medical Center, and you’ve been asked to testify on behalf of the nonpartisan American Academy of Pediatrics (AAP) and its 67,000 members on this issue. In preparing your testimony, consider the current Administration’s commitment to enforcing strict immigration policy with limited federal resources. Your response should include any alternative policy recommendations your organization would support to simultaneously protect our borders and immigrant children’s health.
House Democrats have become increasingly critical of The Trump Administration’s homeland security policies, including indefinite detention of children and family separation. The US House of Representatives Committee on Homeland Security is convening health professionals to discuss how such policies might contribute to adverse childhood experiences (ACEs) in a hearing entitled, “Adverse Impacts of Department of Department of Homeland Security Policies on Children.”
You are a pediatrician at Children’s National Medical Center, and you’ve been asked to testify on behalf of the nonpartisan American Academy of Pediatrics (AAP) and its 67,000 members on this issue. In preparing your testimony, consider the current Administration’s commitment to enforcing strict immigration policy with limited federal resources. Your response should include any alternative policy recommendations your organization would support to simultaneously protect our borders and immigrant children’s health.
Question #3: Surprise Medical Billing
“Surprise medical bills” often refer to charges incurred when an insured individual inadvertently receives care from an out-of-network provider. Among adults struggling to pay medical bills, charges related to out-of-network care are a frequent contributing factor. Accordingly, a bipartisan Senate working group is developing legislation to protect patients from surprise medical bills.
You are the Vice President of Professional Satisfaction and Practice Sustainability at the American Medical Association (AMA). You have been asked to provide the Senate working group with technical assistance. What proposed policy solutions might the AMA endorse to protect patients from surprise out-of-network bills while preserving fair reimbursement for providers?
“Surprise medical bills” often refer to charges incurred when an insured individual inadvertently receives care from an out-of-network provider. Among adults struggling to pay medical bills, charges related to out-of-network care are a frequent contributing factor. Accordingly, a bipartisan Senate working group is developing legislation to protect patients from surprise medical bills.
You are the Vice President of Professional Satisfaction and Practice Sustainability at the American Medical Association (AMA). You have been asked to provide the Senate working group with technical assistance. What proposed policy solutions might the AMA endorse to protect patients from surprise out-of-network bills while preserving fair reimbursement for providers?
Question #4: Drug Pricing
According to a recent Kaiser Family Foundation poll, 79% of Americans say the cost of prescription drugs is unreasonable. Addressing drug pricing has become a Congressional priority. The Health Subcommittee of the US House of Representatives Committee on Energy and Commerce is holding a series of hearings to better understand the issue.
You direct Research and Development at Gilead, a domestic biopharmaceutical company. You have been invited as a witness to a hearing entitled, “Lowering the Cost of Prescription Drugs: Reducing Barriers to Market Competition.” In developing your testimony, consider three pieces of proposed legislation to address skyrocketing drug costs and prepare to deliver your recommendation.
According to a recent Kaiser Family Foundation poll, 79% of Americans say the cost of prescription drugs is unreasonable. Addressing drug pricing has become a Congressional priority. The Health Subcommittee of the US House of Representatives Committee on Energy and Commerce is holding a series of hearings to better understand the issue.
You direct Research and Development at Gilead, a domestic biopharmaceutical company. You have been invited as a witness to a hearing entitled, “Lowering the Cost of Prescription Drugs: Reducing Barriers to Market Competition.” In developing your testimony, consider three pieces of proposed legislation to address skyrocketing drug costs and prepare to deliver your recommendation.
